BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2016
View Archived Issues
Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz
Read More
Prokarium receives funding to develop three new vaccines
Read More
Cerecor announces research grant for the development of CERC-501
Read More
SRI International patents MAP4K4 inhibitors
Read More
Scripps Research Institute discloses agents to treat cancer
Read More
PTC provides E.U. and U.S. update on Translarna program
Read More
Interim data from REMARC study of Revlimid do not support regulatory filing
Read More
Parion Sciences begins phase II study of P-321
Read More
Genentech and Constellation Pharmaceuticals develop KAT2B inhibitors
Read More
Genentech and Constellation Pharmaceuticals jointly patent KDM2B inhibitors
Read More
NantHealth and University of Utah partner on Heritage 1K project
Read More
Kite Pharma licenses technology from UCLA
Read More
First-in-human data on BACE1 inhibitor LY-3202626
Read More
NY-ESO SPEAR T-cell therapy receives orphan drug designation in the E.U.
Read More
First patient dosed in phase III study of roxadustat in Japan
Read More
Tokai to discontinue ARMOR3-SV study of galeterone based on DMC recommendation
Read More
Embera Neurotherapeutics receives grant to continue development of drug for cocaine addition
Read More
Amgen and Novartis report first-in-human data on AMG-520
Read More
Preclinical and early clinical evaluation of MK-8719
Read More
Enigma Biomedical, Biogen and Merck & Co. establish research collaboration
Read More
Results from phase Ib trial evaluating second-generation NGF-ECB implants in patients with AD
Read More
Hisamitsu reports phase II results for HP-3150 analgesic transdermal patch
Read More
Trek Therapeutics gains rights to two HCV drugs from Vertex
Read More
NIAID gives grant to Forge Therapeutics to develop drugs for multidrug-resistant bacteria
Read More
Viking Therapeutics reports results of study in mice with VK-0214
Read More
Merck & Co. returns all rights to SLIT-tablets to ALK-Abello
Read More